Episode summary
Markets punished stocks that beat earnings as investors shift focus from past results to forward guidance. Analyst Algenib breaks down the cautious regime, narrowing breadth, and actionable setups for confirmation-driven trading.
More from The Morning Dose
Morning Dose #367: AI Trade Re-Pricing: Rotation, Not Ruin – Friday 10/23/2026
Fri, Oct 23, 2026Morning Dose #366: Earnings Beats Get Sold, Iran Headlines Spike Oil: A Credibility Test for the Tape – Thursday 10/22/2026
Thu, Oct 22, 2026Morning Dose #365: Breadth Heals, But Meta and Tesla Hold the Verdict – Wednesday 10/21/2026
Wed, Oct 21, 2026Morning Dose #363: Thin Breadth, Thick Risk: Oil Spikes While the Market Hides Its Cracks – Tuesday 10/20/2026
Tue, Oct 20, 2026Morning Dose #362: 404 Bears vs. the Bounce: Trading a Suspect AI Rally – Monday 10/19/2026
Mon, Oct 19, 2026 